Qol Holdings Co., Ltd. (TYO:3034)
Japan
· Delayed Price · Currency is JPY 1,602.00
-7.00 (-0.44%)
Mar 7, 2025, 3:30 PM JST
Qol Holdings Revenue
Qol Holdings had revenue of 73.44B JPY in the quarter ending December 31, 2024, with 59.69% growth. This brings the company's revenue in the last twelve months to 243.73B, up 36.57% year-over-year. In the fiscal year ending March 31, 2024, Qol Holdings had annual revenue of 180.05B with 5.89% growth.
Revenue (ttm)
243.73B
Revenue Growth
+36.57%
P/S Ratio
0.24
Revenue / Employee
41.62M
Employees
5,856
Market Cap
59.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 180.05B | 10.02B | 5.89% |
| Mar 31, 2023 | 170.04B | 3.84B | 2.31% |
| Mar 31, 2022 | 166.20B | 4.37B | 2.70% |
| Mar 31, 2021 | 161.83B | -3.58B | -2.16% |
| Mar 31, 2020 | 165.41B | 20.63B | 14.25% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,170.61B |
| Takeda Pharmaceutical Company | 4,579.02B |
| Daiichi Sankyo Company | 1,795.99B |
| HOYA Corporation | 837.44B |
| Otsuka Holdings | 2,329.86B |
| Terumo | 1,011.15B |
| Astellas Pharma | 1,867.63B |
| Olympus | 993.33B |